Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Allarity Therapeutics, Inc. (ALLR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Allarity Therapeutics, Inc. (ALLR), most recent 12 months reported: revenue $320K, net loss $12.33M, free cash flow -$14.83M. Latest balance sheet on file: liquid cash $16.98M, total debt $22.29M, net cash -$5.3M. From SEC filings. Others in Pharmaceutical Preparations: MEREO BIOPHARMA GROUP PLC · Can-Fite BioPharma Ltd. · PROVECTUS BIOPHARMACEUTICALS, INC. · CervoMed Inc. · REGEN BIOPHARMA, INC. · Clene Inc. · LEXARIA BIOSCIENCE CORP. · Lisata Therapeutics, Inc.

Stock screener

Watchlist